Mounjaro on the NHS: who qualifies and what are your options?

What the NHS actually requires before prescribing Mounjaro

NICE recommended tirzepatide for NHS use in England in December 2024 (updated September 2025), following its appraisal published as TA1026. The recommendation is not a blanket one. To qualify, an adult must have a BMI of 35 or above and at least one weight-related condition from the qualifying list: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, or type 2 diabetes. For people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, the BMI threshold is set 2.5 kg/m² lower throughout.

Access is being released in cohorts. From June 2025, people with a BMI of 40 or above and four or more of those five conditions could access treatment through the NHS. From 23 June 2026, that opened to BMI 35–39.9 with four or more conditions. The next phase (BMI 40 or above with three conditions) is expected around March 2027. If you want to read the criteria in full, the NHS England guidance on weight-management injections sets them out clearly.

Even meeting the criteria doesn't guarantee a prescription. Every NHS patient must also participate in "wrap-around" diet and activity support, and your GP practice has to be participating in the scheme, which is optional. The practical reality is that many eligible people are still waiting.

Getting Mounjaro through your GP, and why it isn't straightforward

From 1 April 2026, GP practices in England can prescribe Mounjaro under the updated QOF contract. That was significant progress. But participation is optional, so whether your practice offers this depends entirely on the decisions of your individual surgery and local ICB. Some practices started prescribing quickly; others have not yet set up the pathway.

If your practice does participate, you'll still need to meet the cohort criteria above, and your GP will refer you into the wrap-around support programme. There is no fast lane. For a more detailed look at how the GP route works in practice, the page on getting Mounjaro through your GP on the NHS covers what to expect at that conversation.

Scotland, Wales and Northern Ireland each operate separate systems with different eligibility thresholds and rollout timelines. If you're outside England, it's worth checking with your GP directly, since the NICE TA1026 criteria apply specifically to NHS England.

Who the NHS route doesn't reach, and the decision that follows

The honest picture is that the majority of adults who would clinically benefit from Mounjaro don't meet the current NHS cohort criteria. BMI between 27 and 34.9 with one weight-related condition is the licensed range for private prescribing, but the NHS is not yet commissioning at that level. Even within the qualifying BMI bands, needing fewer than four conditions rules many people out until later phases arrive.

That gap is why regulated private pharmacies exist. Private prescribing follows the licensed eligibility criteria set out in the Mounjaro SmPC (adults with a BMI of 30 or above, or 27 or above with a qualifying weight-related condition) assessed by a prescriber on the individual's full clinical picture. If you're thinking about the cost of going privately, the Mounjaro treatment overview explains what a private prescription typically involves and what to look for in a provider.

One thing worth checking before anything else: any online pharmacy prescribing Mounjaro should be verifiable on the GPhC register at pharmacyregulation.org/registers. That takes about 30 seconds and tells you whether the pharmacy is operating legally. It's the single most useful check you can do.

Choosing between waiting for the NHS and going private

This is the real decision most people reading this page face. It isn't purely financial, though the cost of private treatment is a fair factor. It's also about time, eligibility, and how much weight management matters to your health right now.

Some people find it worth waiting, particularly if they're close to meeting the NHS criteria and their GP practice is actively setting up the pathway. Others (especially those with a BMI below 35, or fewer than four qualifying conditions) are likely to be waiting several years before the NHS rollout reaches them, if it does.

Privately, a legitimate service should include a clinical consultation (reviewed by a GPhC-registered prescriber, not automated software), identity and weight verification, and proper aftercare. Speed matters in another way too: the pen lives in the fridge between doses, and a reliable supply chain from a GPhC-registered pharmacy means you're not left without your next pen mid-treatment. If you want to explore whether private treatment is an option for you, you can check your eligibility with our prescribers at no charge.

For more on the distinction between NHS and private access routes, the guide to getting Mounjaro on the NHS goes further into the process, the page on buying Mounjaro through the NHS covers the practical steps for those who qualify, and the overview of buying Mounjaro online covers what to expect from the private route. If you ever need to pause or stop treatment, it is also worth knowing that there is guidance on how to get Mounjaro out of your system faster should that become relevant for you.